- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 25.08. | Advanced Therapies Europe 2026 to put Europe's CGT competitiveness under the spotlight | ||
| 25.08. | BeOne Medicines, BeOne Care Foundation and The Max Foundation renew partnership | ||
| 24.08. | LEO Pharma acquires rights for dersimelagon from Tanabe Pharma | ||
| 24.08. | LEO Pharma acquire rights for dersimelagon from Tanabe Pharma | ||
| 24.08. | Lucid Group appoints Eric Muller as CEO | ||
| 21.08. | 'Switchable' smart gel may pave the way for next-gen drug delivery and sensing tech | ||
| 21.08. | Creating a strong patent portfolio through constant communication | ||
| 20.08. | Merck and Moderna announce potential new vaccine for melanoma | ||
| 20.08. | Leading through complexity | ||
| 19.08. | NICE recommends axunio's Axhidrox cream for adults with severe hyperhydrosis | ||
| 19.08. | The Amazon reckoning: GLP-1s and the consumer lifestyle shift - why the molecule is no longer enough | ||
| 18.08. | Lupus - moving patient care beyond current therapies towards resetting the immune system | ||
| 18.08. | Pfizer and Valneva's application for Lyme disease vaccine candidate validated by EMA | ||
| 17.08. | NRG Therapeutics appoints Claus Sundgreen as Chief Medical Officer | ||
| 17.08. | Sandoz announces collaboration agreement with Shanghai Henlius Biotech | ||
| 17.08. | BeOne Medicines appoints Kandeepan Ganeshalingam as Vice President, Head of Medical Affairs, Europe | ||
| 14.08. | Bristol Myers Squibb announces new $2.3bn campus in the US | ||
| 14.08. | Richmond Pharmacology appoints Adam Hurd as Operations Director | ||
| 13.08. | FDA grants Fast Track status for peanut allergy immunotherapy | ||
| 13.08. | CNX Therapeutics appoints Lucy Ralph as Chief People and Transformation Officer | ||
| 12.08. | Ipsen's cabozantinib accepted by SMC for adults with advanced neuroendocrine tumours | ||
| 12.08. | Healthcare Communications Association appoints Emma Kenny as new interim CEO | ||
| 11.08. | Eli Lilly's Foundayo authorised by UK MHRA for weight loss and type 2 diabetes | ||
| 11.08. | EHP Awards 2027 open for entries following outstanding inaugural year | ||
| 10.08. | NICE recommends treatments for mantle cell lymphoma and chronic lymphocytic leukaemia |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.